obsolete_cystic fibrosis: ['A congenital metabolic disorder affecting the exocrine glands, inherited as an autosomal trait. The secretions of exocrine glands are abnormal, resulting in excessively viscid mucus production which causes obstruction of passageways (including pancreatic and bile ducts, intestines, and bronchi). The sweat sodium and chloride content are increased. Symptoms usually appear in childhood and include meconium ileus, poor growth despite good appetite, malabsorption and foul bulky stools, chronic bronchitis with cough, recurrent pneumonia, bronchiectasis, emphysema, clubbing of the fingers, and salt depletion in hot weather. -- 2003', 'A congenital metabolic disorder affecting the exocrine glands, inherited as an autosomal trait. The secretions of exocrine glands are abnormal, resulting in excessively viscid mucus production which causes obstruction of passageways (including pancreatic and bile ducts, intestines, and bronchi). The sweat sodium and chloride content are increased. Symptoms usually appear in childhood and include meconium ileus, poor growth despite good appetite, malabsorption and foul bulky stools, chronic bronchitis with cough, recurrent pneumonia, bronchiectasis, emphysema, clubbing of the fingers, and salt depletion in hot weather.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
68 |
4. Check minimum number of eventsNone |
68 |
5. Include endpoints |
87 |
6. Filter based on genotype QC (FinnGen only) |
87 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E70-E90
- Name in latin
- Fibrosis cystica
Similar endpoints
↥List of similar endpoints to
Cystic fibrosis
based on the number of shared cases.
Similar with more cases:
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 672 | 324 | 341 |
| Only index persons | 504 | 255 | 249 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.01 | 0.01 |
| Only index persons | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 51.06 | 55.29 | 46.77 |
| Only index persons | 51.08 | 55.07 | 46.99 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 87 | 49 | 38 |
| Unadjusted period prevalence (%) | 0.02 | 0.02 | 0.02 |
| Median age at first event (years) | 35.27 | 33.91 | 37.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 79
- Matched controls
- 790
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
+∞
51.9
44
*
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
+∞
46.5
40
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
+∞
40.0
35
*
A09AA02
ATC
multienzymes (lipase, protease etc.)
649.5
39.8
36
*
304
Kela drug reimbursment
Dornase alfa
+∞
35.0
31
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
35.0
31
*
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
+∞
30.1
27
*
J01GB01
ATC
tobramycin; inhalant, parenteral
+∞
28.9
26
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
28.8
25.4
35
21
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
76.0
23.8
26
5
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
+∞
23.0
21
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
32.5
21.4
28
13
L04AA06
ATC
mycophenolic acid; systemic
246.1
19.5
19
*
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
18.4
17
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
22.1
18.4
27
18
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
42.6
18.2
22
7
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
17.4
17.3
28
24
J01XB01
ATC
colistin; inhalant, parenteral
+∞
17.3
16
*
Z94.2
ICD-10 Finland
Lung transplant status
+∞
17.3
16
*
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
213.2
17.2
17
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
8.8
16.8
44
98
GD1AA
NOMESCO Finland
Thorax X-ray examination
7.9
16.1
58
204
UDH02
NOMESCO Finland
Rhinopharyngoscopy
16.8
15.5
25
21
J32.4
ICD-10 Finland
Chronic pansinusitis
71.0
15.5
17
*
R4190
NOMESCO Finland
Nutritional therapy
25.4
15.2
21
11
127
Kela drug reimbursment
Transplant complication
45.8
15.2
18
5
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
+∞
15.1
14
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
182.3
15.0
15
*
TGC00
NOMESCO Finland
Bronchial lavation
38.1
14.6
18
6
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
21.4
14.4
21
13
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
14.0
13
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
24.5
13.7
19
10
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
14.9
13.7
23
21
TDM10
NOMESCO Finland
Puncture of maxillary antrum
20.1
13.5
20
13
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
7.1
13.4
40
100
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
6.8
13.4
42
113
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
12.8
12
*
E84
ICD-10 Finland
Cystic fibrosis
+∞
12.8
12
*
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
153.4
12.8
13
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
20.7
12.4
18
11
J01MA12
ATC
levofloxacin; systemic
7.8
12.3
31
60
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
15.3
12.2
20
17
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
8.6
11.7
27
45
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
10.7
11.7
23
29
Z31.5
ICD-10 Finland
Genetic counselling
15.2
11.6
19
16
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
5.8
11.6
41
123
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
13.0
11.3
20
20
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
11.5
11.2
21
24
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
12.1
10.5
19
20
602
Kela drug reimbursment
Children's severe malnutrition
30.6
10.2
13
5
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
30.6
10.2
13
5
XG410
NOMESCO Finland
Flow-volume spirometry
12.6
10.2
18
18
R03AK06
ATC
salmeterol and fluticasone; inhalant
7.2
10.1
26
50
J33.0
ICD-10 Finland
Polyp of nasal cavity
18.1
10.0
15
10
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
6.5
10.0
28
61
WX404
NOMESCO Finland
Intravenous generell anesthesy
5.7
9.8
32
84
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
34.8
9.7
12
*
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
34.8
9.7
12
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
+∞
9.6
9
*
R07AX02
ATC
ivacaftor; oral
+∞
9.6
9
*
27300
ICD-8 Finland
Other and unspecified congenital disorders of metabolism, Cystic fibrosis (mucoviscidosis)
+∞
9.6
9
*
RS123
NOMESCO Finland
NA
+∞
9.6
9
*
3045
Kela drug reimbursment
NA
+∞
9.6
9
*
R07AX32
ATC
ivacaftor, tezacaftor and elexacaftor; oral
+∞
9.6
9
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
18.5
9.4
14
9
J01CF05
ATC
flucloxacillin; systemic
13.0
9.3
16
15
R4110
NOMESCO Finland
Physiotherapy
5.0
9.3
36
114
UDM02
NOMESCO Finland
Sinoscopy
27.9
9.2
12
5
GD1AD
NOMESCO Finland
Thorax CT examination
13.9
9.0
15
13
R03AC02
ATC
salbutamol; inhalant
4.6
9.0
58
296
Z3229
NOMESCO Finland
Other healthcare associate professional
8.0
8.7
20
32
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.8
8.6
26
61
XX4BW
NOMESCO Finland
NA
100.3
8.6
9
*
J01MA14
ATC
moxifloxacin; systemic
7.7
8.6
20
33
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
17.0
8.5
13
9
TPH04
NOMESCO Finland
Cathetrisation of vein
5.4
8.5
28
73
B05XA03
ATC
sodium chloride; parenteral
+∞
8.5
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
9.5
8.4
17
22
Z2446
NOMESCO Finland
Social worker
8.6
8.4
18
26
ZX120
NOMESCO Finland
Intravenous
8.6
8.4
18
26
A02BA03
ATC
famotidine; systemic
25.1
8.3
11
5
R04.2
ICD-10 Finland
Haemoptysis
25.1
8.3
11
5
J01MA02
ATC
ciprofloxacin; systemic
4.1
8.1
42
170
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
11.9
7.9
14
14
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
6.4
7.8
21
42
A05AA02
ATC
ursodeoxycholic acid; oral
21.0
7.8
11
6
R05CB02
ATC
bromhexine; systemic
88.0
7.6
8
*
J47
ICD-10 Finland
Bronchiectasis
17.9
7.5
11
7
R03BA05
ATC
fluticasone; inhalant
4.3
7.5
32
108
H02AB06
ATC
prednisolone; systemic
3.8
7.5
47
221
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
7.7
7.4
17
27
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
+∞
7.4
7
*
DPA30
NOMESCO Finland
Sphenotomy
+∞
7.4
7
*
WX872
NOMESCO Finland
Intensive care
11.7
7.4
13
13
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.7
7.4
13
13
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
33.4
7.3
9
*
UJF32
NOMESCO Finland
Coloscopy
4.4
7.1
28
87
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
44.0
6.9
8
*
A07AA02
ATC
nystatin; oral
9.5
6.6
13
16
R01AD08
ATC
fluticasone; nasal
3.7
6.6
36
144
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
10.6
6.6
12
13
Z94.0
ICD-10 Finland
Kidney transplant status
75.7
6.5
7
*
Z3226
NOMESCO Finland
Physiotherapist
4.2
6.5
27
87
B02AA02
ATC
tranexamic acid; systemic
6.3
6.5
17
33
103
Kela drug reimbursment
Diabetes, insulin-treated
4.1
6.5
28
94
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
29.3
6.4
8
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.6
6.3
23
65
J02AC04
ATC
posaconazole; systemic
+∞
6.3
6
*
V07AB
ATC
Solvents and diluting agents, incl. irrigating solutions
+∞
6.3
6
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
7.5
6.2
14
22
SPAT1262
SPAT
Handing over of treatment supplies
4.3
6.1
24
73
UDC00
NOMESCO Finland
Ear microscopy
6.2
6.1
16
31
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
6.1
35
147
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
16.7
6.1
9
6
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
16.7
6.1
9
6
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
10.4
6.0
11
12
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
28
12
33.93
40.27
6.2
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
26
10
36.66
38.69
4.6
1.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
44
64
12.89
32.29
12.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
26
16
22.75
31.94
4.7
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
26
16
22.75
31.94
5.4
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
14
23.29
30.10
22.9
4.1
iu/ml
107.4
—
—
5
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
22
13
22.31
27.29
4.9
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
13
22.31
27.29
5.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
19
10
24.03
24.63
4.9
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
10
24.03
24.63
5.5
1.2
—
—
—
0
0
(4010399)
30
44
9.88
21.04
3.5
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
41
90
7.72
20.07
5.5
2.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
34
63
8.22
19.43
4.4
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
34
64
8.08
19.13
4.7
1.7
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
22
6
48.20
18.67
17.6
2.3
—
—
—
0
0
(3000492) Spirometry study
33
64
7.70
17.95
3.7
1.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
38
87
6.98
17.56
5.1
2.1
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
36
80
6.97
17.09
4.7
2.1
%
19.5
22.8
0.65
30
69
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
9
32.07
17.03
4.6
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
51
159
6.33
16.85
10.7
3.1
ph
7.4
7.4
0.66
20
32
(44790049)
20
6
42.53
16.59
4.3
1.2
—
—
—
0
0
(44790048)
20
6
42.53
16.59
4.3
1.2
—
—
—
0
0
(44790047)
20
6
42.53
16.59
4.3
1.2
—
—
—
0
0
(44806118)
20
6
42.53
16.59
4.3
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
31
62
7.21
16.24
4.5
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
65
267
6.67
15.29
21.6
4.4
mmol/l
1.2
1.2
0.45
52
222
(42870588) Differential panel, method unspecified - Blood
56
214
5.54
13.98
26.3
5.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
13
11
13.72
12.93
3.5
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
26
54
6.44
12.88
9.1
3.9
%
0.8
0.4
—
8
12
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
45
152
5.06
12.85
4.4
1.6
mg/l
1.3
0.9
0.26
30
105
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
10
13.76
11.99
4.3
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
42
141
4.83
11.93
10.1
4.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
38
6.97
11.83
3.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
25
54
6.09
11.83
9.6
4.0
%
0.0
0.1
—
8
15
(3017181) Myelocytes/100 leukocytes in Blood
26
60
5.75
11.44
9.6
3.7
%
0.7
0.8
—
10
21
(3021440) Promyelocytes/100 leukocytes in Blood
25
57
5.75
11.12
10.0
3.8
%
0.0
0.2
—
9
18
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
14
10.74
11.05
8.4
4.4
e9/l
5.5
3.6
1.02
13
14
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
12
11.44
10.68
3.9
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
10
0
+∞
10.63
3.6
0.0
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
52
221
4.36
10.52
7.5
6.0
inr
1.1
1.1
0.04
24
74
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
15
10.01
10.51
8.5
4.7
%
61.2
50.9
1.87
13
15
(3002030) Lymphocytes/100 leukocytes in Blood
66
337
4.97
10.31
28.6
5.2
%
27.6
29.2
0.74
61
318
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
5
30.14
10.14
2.8
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
13
5
30.14
10.14
19.1
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
62
307
4.55
9.97
28.0
8.2
e9/l
0.0
0.0
0.00
52
251
(3001604) Monocytes [#/volume] in Blood
66
343
4.83
9.91
27.9
5.4
e9/l
0.7
0.6
1.11
60
313
(3006315) Basophils [#/volume] in Blood
66
343
4.83
9.91
27.9
5.4
e9/l
0.0
0.0
0.14
60
314
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
8
20.51
9.77
2.7
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
16
28
6.78
9.18
2.2
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
20
45
5.47
8.90
6.1
3.6
mmol/l
1.2
1.2
0.12
20
40
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
40
158
3.84
8.62
2.2
1.5
mmol/l
1.3
1.4
0.13
34
136
(3012516) Albumin [Mass/volume] in Urine
38
145
3.88
8.61
4.3
2.9
mg/l
131.1
75.9
0.28
28
85
(3007164) IgA [Mass/volume] in Serum or Plasma
40
162
3.72
8.24
3.1
1.5
g/l
2.7
2.6
0.03
31
86
(3020682) Albumin/Creatinine [Ratio] in Urine
39
156
3.72
8.18
5.7
3.6
mg/mmol
19.2
11.9
0.25
29
90
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
12
8
17.11
7.98
4.3
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
41
173
3.59
7.87
17.6
5.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
17
37
5.47
7.79
7.0
2.5
kpa
5.2
5.1
0.15
17
32
(3013650) Neutrophils [#/volume] in Blood by Automated count
68
400
4.21
7.70
29.6
9.0
e9/l
4.2
4.0
0.41
62
362
(3003396) Base excess in Arterial blood by calculation
20
51
4.79
7.66
8.7
4.4
mmol/l
0.9
0.5
0.12
15
38
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
7
17.72
7.45
2.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
0
+∞
7.39
2.4
0.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
26
85
3.94
7.20
1.5
1.4
titre
176.0
480.0
—
5
15
(3009508) Creatinine [Moles/volume] in Urine
40
179
3.29
6.80
4.3
3.0
mmol/l
7.1
8.0
0.46
34
149
(36304419) Bacteria [Presence] in Urine
41
187
3.26
6.74
6.4
2.7
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
6
0
+∞
6.32
4.8
0.0
mg/l
2.0
—
—
6
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
6
0
+∞
6.32
1.0
0.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
6
0
+∞
6.32
6.0
0.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
14
31
5.19
6.24
1.6
3.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
35
152
3.18
6.16
12.1
2.1
umol/l
411.2
3573.8
0.48
30
127
(3030467) Casts [#/volume] in Urine by Automated count
40
189
3.07
6.07
6.8
2.7
e6/l
0.0
0.3
1.79
35
140
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
11
20
6.15
5.97
1.2
1.2
—
—
—
0
0
(4306422)
10
9
12.35
5.96
1.2
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
45
231
2.96
5.84
7.9
3.0
—
—
—
0
0
(3012544) pH of Venous blood
18
54
3.94
5.52
8.3
3.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
45
240
2.81
5.31
8.3
3.7
e6/l
75.8
46.5
0.19
40
172
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
0
+∞
5.25
1.2
0.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
0
+∞
5.25
1.2
0.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
6
14.49
5.19
2.3
3.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
6
14.49
5.19
1.1
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
28
4.81
5.00
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
37
183
2.78
4.98
1.7
1.4
u/ml
0.4
1.2
—
7
29
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
8
7
12.41
4.89
1.1
1.4
%
73.6
112.4
—
8
7
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
39
4.09
4.71
1.2
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
26
110
2.94
4.63
5.8
2.8
e6/l
2.1
1.4
0.33
19
60
(3021901) Oxygen saturation in Capillary blood
8
8
10.85
4.62
2.8
2.9
—
—
—
0
0
(4035726)
16
50
3.70
4.60
1.6
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
11
26
4.70
4.50
16.4
3.4
mmol/l
25.3
24.9
0.09
11
26
(1616796) Gas panel - Central venous blood
9
12
8.21
4.47
6.1
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
18
66
3.18
4.05
1.1
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
24
104
2.81
4.05
1.8
1.6
nmol/l
1259.8
1252.7
0.01
15
73
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
40
225
2.44
3.97
2.4
1.7
pmol/l
79.7
98.9
1.79
23
103
(3000991) Gas panel - Venous blood
14
45
3.52
3.85
18.1
4.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
8
9.38
3.84
2.7
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
6
5
12.74
3.82
2.8
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
12
7.21
3.76
1.1
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
34
183
2.41
3.66
3.9
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
17
64
3.06
3.65
1.1
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
33
176
2.41
3.62
18.6
4.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
38
217
2.33
3.57
4.6
3.1
ng/l
36.4
43.1
0.12
28
135
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
18
5.44
3.47
1.4
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
18
5.44
3.47
1.4
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
16
60
3.04
3.45
3.9
2.9
u/l
26.3
27.2
0.05
11
55
(3035350) Ketones [Presence] in Urine by Test strip
49
315
2.27
3.45
4.9
3.3
estimate
0.0
0.0
0.00
17
70
(40768804) Tissue Pathology biopsy report
41
245
2.27
3.43
3.4
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
10
7.49
3.43
4.0
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
49
320
2.22
3.26
7.3
4.3
estimate
0.0
0.0
0.00
19
69
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
20
4.89
3.21
13.9
4.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
78
640
3.11
3.20
6.1
3.7
mmol/l
1.4
1.5
0.28
72
580
(3052851) Hemolysis interference index of Serum or Plasma
8
16
5.39
3.13
1.8
2.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
12
6.23
3.08
1.1
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
12
6.23
3.08
1.1
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
78
645
3.02
3.03
6.3
3.8
mmol/l
4.1
4.6
4.81
72
590
(3034426) Prothrombin time (PT)
5
5
10.49
3.01
1.2
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
10
30
3.64
3.01
2.5
1.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
49
328
2.13
2.97
5.1
3.3
estimate
0.0
0.0
0.00
18
69
(3034770) Mitochondria Ab [Titer] in Serum
7
13
5.75
2.93
1.9
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
76
612
2.91
2.92
5.4
3.4
mmol/l
1.4
1.2
0.84
69
553
(3037756) Immunofixation for Serum or Plasma
6
9
7.06
2.91
1.0
1.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
16
67
2.70
2.83
4.7
3.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
5
6
8.74
2.78
3.0
3.3
mu/l
12.9
15.3
—
5
6
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
6
8.74
2.78
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
6
8.74
2.78
2.8
3.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
78
656
2.82
2.69
6.4
4.1
mmol/l
2.2
2.8
7.86
72
593
(3037467) Urinalysis macro (dipstick) panel - Urine
60
446
2.11
2.63
10.9
3.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
70
2.58
2.60
1.8
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
32
190
2.08
2.59
4.9
2.9
—
—
—
0
0
(4268621)
6
11
5.77
2.59
2.3
2.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
11
5.77
2.59
1.8
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
6
11
5.77
2.59
1.2
1.5
mg/l
16.4
12.5
—
6
11
(3035637) Corticotropin [Mass/volume] in Plasma
5
7
7.49
2.58
2.4
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
7
7.49
2.58
1.4
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
7
7.49
2.58
1.6
1.4
—
—
—
0
0
(3015736) pH of Urine
38
241
2.02
2.57
4.1
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
25
135
2.20
2.57
4.0
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
25
135
2.20
2.57
3.4
3.4
—
—
—
0
0
(3044889) 12 lead EKG panel
58
428
2.07
2.56
9.2
3.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
16
4.66
2.53
2.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
67
524
2.21
2.51
5.9
3.6
pmol/l
14.5
14.7
0.24
61
471
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
114
2.24
2.49
5.1
2.6
e6/l
0.8
0.7
0.08
15
62
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
76
628
2.66
2.47
7.4
4.2
mu/l
2.1
1.8
1.16
69
563
(3022313) Gas panel - Capillary blood
9
27
3.59
2.47
11.2
2.8
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
8
6.54
2.40
5.8
1.3
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
8
6.54
2.40
1.8
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
78
665
2.67
2.37
40.6
11.0
%
37.4
40.4
2.08
61
496
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
60
2.59
2.36
5.3
3.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
23
3.72
2.33
2.0
1.7
g/l
0.2
0.2
—
8
23
(3013290) Carbon dioxide [Partial pressure] in Blood
6
13
4.87
2.31
8.7
1.5
kpa
5.0
4.8
—
6
13
(3027315) Oxygen [Partial pressure] in Blood
6
13
4.87
2.31
8.5
1.5
kpa
8.3
9.0
—
6
13
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
75
623
2.48
2.29
34.7
10.2
ml/min/173m2
85.5
89.1
0.45
66
480
(40760888) Immunoglobulin light chains.free panel - Serum
5
9
5.81
2.24
1.2
2.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
5
10
5.23
2.10
1.6
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
15
4.21
2.07
2.2
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
29
182
1.89
1.94
4.6
3.7
estimate
0.0
0.0
0.00
16
66
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
22
3.37
1.92
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
28
3.04
1.91
1.3
2.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
37
252
1.81
1.91
5.1
3.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
17
3.71
1.87
1.5
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
17
3.71
1.87
1.5
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
6
18
3.50
1.78
2.2
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
19
3.31
1.69
2.0
2.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
82
744
2.78
1.67
33.9
10.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
6
20
3.14
1.61
2.0
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
19
110
1.93
1.59
2.4
2.8
ng/l
1537.8
217.3
1.12
12
72
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
41
301
1.68
1.56
6.2
3.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
19
111
1.91
1.55
1.3
1.4
iu/ml
28.5
18.5
—
6
31
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
78
699
2.12
1.50
52.9
11.0
mg/l
16.9
21.3
1.23
71
512
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
16
3.25
1.46
1.8
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
7
29
2.53
1.42
20.1
4.3
%
95.6
93.4
—
7
29
(3020891) Body temperature
6
24
2.61
1.33
1.3
4.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
18
2.88
1.30
2.4
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
13
72
1.95
1.23
1.5
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
33
0.00
1.19
0.0
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
72
638
1.75
1.13
5.9
3.7
mmol/l
6.2
5.7
2.27
66
573
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
7
31
2.37
1.13
20.1
4.0
%
0.9
0.8
—
7
31
(3013512) EKG study
25
174
1.61
1.12
5.8
3.0
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
7
32
2.29
1.11
20.1
4.0
%
1.3
1.9
—
7
32
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
22
2.35
1.05
9.8
2.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
27
195
1.56
1.03
2.8
2.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
28
0.00
0.99
0.0
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
28
0.00
0.99
0.0
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
28
0.00
0.99
0.0
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
30
0.00
0.99
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
30
0.00
0.99
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
30
0.00
0.99
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
30
0.00
0.99
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
30
0.00
0.99
0.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
30
0.00
0.99
0.0
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
14
86
1.75
0.98
1.1
2.3
ug/g
219.0
102.1
—
8
64
(36660697) Celiac disease serology panel - Serum
12
71
1.80
0.94
1.7
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
111
0.51
0.91
1.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
31
2.00
0.86
2.2
1.1
—
—
—
0
0
(3019225) pH of Specimen
8
46
1.81
0.85
11.5
3.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
12
75
1.70
0.80
2.2
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
5
23
2.24
0.77
8.0
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
24
2.15
0.76
1.8
1.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
26
1.98
0.72
3.8
2.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
26
1.98
0.72
8.6
4.7
%
54.5
43.6
—
5
26
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
120
1.52
0.71
2.3
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
5
27
1.90
0.69
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
51
1.63
0.62
1.0
2.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
52
1.59
0.61
1.0
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
52
1.59
0.61
1.0
2.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
52
1.59
0.61
1.0
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
14
190
0.69
0.57
1.4
1.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
37
1.67
0.57
1.0
2.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
21
163
1.38
0.55
2.1
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
24
193
1.34
0.51
2.1
2.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
7
45
1.60
0.50
3.4
3.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
48
1.50
0.48
1.0
2.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
5
31
1.65
0.44
6.2
2.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
25
210
1.27
0.38
1.4
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
58
542
1.21
0.31
4.1
3.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
148
0.78
0.27
1.5
2.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
11
134
0.79
0.22
1.5
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
14
118
1.22
0.20
1.1
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
58
1.22
0.19
1.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
88
0.78
0.15
1.7
2.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
47
1.07
0.09
3.2
2.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
12
107
1.14
0.09
1.5
1.3
u/ml
1.0
5.7
—
6
46
(1761868) Lipid panel - Serum or Plasma
23
238
0.95
0.02
3.8
2.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
134
0.96
0.00
1.5
2.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
5
52
0.96
0.00
1.2
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
1.2
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
15.6
—
0
8
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
7
73
0.96
0.00
17.6
5.6
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
96.0
—
0
8
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
18.0
—
1292.5
—
0
6
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
237.2
—
0
6
(21494890) Protein electrophoresis panel - 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
16.3
—
809.2
—
0
6
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
3.8
—
49.8
—
0
6
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
8
0.00
0.00
0.0
1.0
—
13.6
—
0
8
Mortality – FinRegistry
↥Association
Association between endpoint E4_CYSTFIBRO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_CYSTFIBRO | 1.906 [1.37, 2.65] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.052 |
During the follow-up period (1.1.1998 — 31.12.2019), 76 out of 217 females with E4_CYSTFIBRO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_CYSTFIBRO | 3.247 [2.14, 4.92] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 97 out of 225 males with E4_CYSTFIBRO died.
Mortality risk
Mortality risk for people of age
years, who have E4_CYSTFIBRO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.193% | 0.647% |
| 5 | 1.046% | 3.558% |
| 10 | 2.484% | 9.085% |
| 15 | 4.779% | 17.249% |
| 20 | 8.026% | 28.099% |
Relationships between endpoints
↥Index endpoint: E4_CYSTFIBRO – Cystic fibrosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data